You have free access to this content

Alimentary Pharmacology & Therapeutics

Cover image for Alimentary Pharmacology & Therapeutics

September 2002

Volume 16, Issue 9

Pages 1579–1688

  1. Review Articles

    1. Top of page
    2. Review Articles
    3. Original Articles
    1. You have free access to this content
      Biological agents in the treatment of Crohn's disease (pages 1579–1590)

      R. Caprilli, A. Viscido and D. Guagnozzi

      Version of Record online: 28 AUG 2002 | DOI: 10.1046/j.1365-2036.2002.01319.x

    2. You have free access to this content
      Lactose — a potential prebiotic (pages 1591–1602)

      A. Szilagyi

      Version of Record online: 28 AUG 2002 | DOI: 10.1046/j.1365-2036.2002.01321.x

  2. Original Articles

    1. Top of page
    2. Review Articles
    3. Original Articles
    1. You have free access to this content
      The quality of life in patients with Crohn's disease (pages 1603–1609)

      R. D. Cohen

      Version of Record online: 28 AUG 2002 | DOI: 10.1046/j.1365-2036.2002.01323.x

    2. You have free access to this content
    3. You have free access to this content
      Meta-analysis: ribavirin-induced haemolytic anaemia in patients with chronic hepatitis C (pages 1623–1632)

      C. H. Chang, K. Y. Chen, M. Y. Lai and K. A. Chan

      Version of Record online: 28 AUG 2002 | DOI: 10.1046/j.1365-2036.2002.01326.x

    4. You have free access to this content
      Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in ‘real world’ patients with chronic hepatitis C (pages 1633–1639)

      G. B. Gaeta, D. F. Precone, F. M. Felaco, R. Bruno, A. Spadaro, G. Stornaiuolo, M. Stanzione, T. Ascione, R. De Sena, A. Campanone, G. Filice and F. Piccinino

      Version of Record online: 28 AUG 2002 | DOI: 10.1046/j.1365-2036.2002.01331.x

    5. You have free access to this content
    6. You have free access to this content
      Naloxone treatment for irritable bowel syndrome — a randomized controlled trial with an oral formulation (pages 1649–1654)

      N. D. Hawkes, J. Rhodes, B. K. Evans, P. Rhodes, A. B. Hawthorne and G. A. O. Thomas

      Version of Record online: 28 AUG 2002 | DOI: 10.1046/j.1365-2036.2002.01320.x

    7. You have free access to this content
    8. You have free access to this content
    9. You have free access to this content
      Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication (pages 1669–1675)

      B.-S. Sheu, J. -J. Wu, C. -Y. Lo, H. -W. Wu, J. -H. Chen, Y. -S. Lin and M. -D. Lin

      Version of Record online: 28 AUG 2002 | DOI: 10.1046/j.1365-2036.2002.01335.x

    10. You have free access to this content
      Foetal intrauterine growth restrictions with Helicobacter pylori infection (pages 1677–1682)

      G. D. Eslick, P. Yan, H. H.-X. Xia, H. Murray, B. Spurrett and N. J. Talley

      Version of Record online: 28 AUG 2002 | DOI: 10.1046/j.1365-2036.2002.01333.x

    11. You have free access to this content
      Effects of enteric-coated, low-dose aspirin on parameters of platelet function (pages 1683–1688)

      A. Van Hecken, M. L. Juliano, M. Depré, I. De Lepeleire, J. Arnout, A. Dynder, L. Wildonger, K. J. Petty, K. Gottesdiener and J. N. De Hoon

      Version of Record online: 28 AUG 2002 | DOI: 10.1046/j.1365-2036.2002.01332.x

SEARCH

SEARCH BY CITATION